Novartis To Allow Leukemia Drug Generics In Some Areas
Pharmaceutical companies in about half a dozen countries will be allowed to make generic versions of a leukemia drug made by pharma giant Novartis, helping to boost the ability of patients...To view the full article, register now.
Already a subscriber? Click here to view full article